Expert Video - What is a clinical trial for MDS? Why are they important?

Dr. Amy E. DeZern, a professor of oncology at The Johns Hopkins University School of Medicine, explains what a clinical trial for MDS is and why these studies are important. She explains that a clinical trial is an experimental protocol and can involve the treatment of a patient who has MDS with a drug that has not yet been approved by a regulatory authority. Unfortunately, because there are not as many drugs available for treating MDS, Dr. DeZern describes that an important goal of MDS clinical trials is to develop pathways for new drugs, or other interventions, to offer additional treatment approaches and opportunities for hope for patients with MDS.

  • Share with family and friends:

Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about MDS which will help other patients, caregivers and families.

Other Modules:

 

This educational activity has been developed by the Myelodysplastic Syndromes Foundation, Inc. and Mechanisms in Medicine Inc.

This activity is supported by an educational grant from Acceleron Pharma, Bristol-Myers Squibb, Celgene Corporation, Jazz Pharmaceuticals, Novartis Pharmaceuticals, and Takeda Oncology.

This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.